4.8.12.2Vertical
Laparoscopic & Endoscopic Instruments
Minimally invasive surgical instruments for laparoscopy.
Market snapshot
These figures describe Surgical Instruments & Robotics (4.8.12), the segment that Laparoscopic & Endoscopic Instruments sits within — not Laparoscopic & Endoscopic Instruments on its own.
- Market size
- ~$40B
- Growth
- ~0.3%CAGR (2017–22, nominal)
- Companies
- ~1,300
FragmentationConsolidatedEstimate
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 339112 (Surgical & Medical Instrument Manufacturing) — a broad category also covering orthopedic and endoscopy instruments.
Business model & economics
Revenue model
Capital systems plus high-margin recurring instruments
Key economics
- Recurring revenue
- High
- EBITDA margin
- 20–35%
- Capex intensity
- High
recurring instruments and consumables
razor-and-blade economics
Characteristics
- Robotic surgery is the defining growth story.
- Razor-and-blade model with recurring instrument revenue.
- Strategics investing heavily to compete with Intuitive.
M&A deal context
Deal activityHigh
Who’s acquiring
- Surgical & robotics strategics
- Diversified medtech platforms
- PE- and VC-backed device companies
What’s driving deals
- Competition to build surgical-robotics platforms.
- Strategics acquiring robotics and energy innovation.
- Recurring-instrument razor-and-blade economics.
Find Laparoscopic & Endoscopic Instruments acquisition targets
Search Acquisera’s index for companies classified under Laparoscopic & Endoscopic Instruments (4.8.12.2) and build a targeted deal pipeline.
Search companies